Hinge Health (NYSE:HNGE - Get Free Report) had its price target lifted by equities research analysts at Stifel Nicolaus from $48.00 to $55.00 in a report released on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Stifel Nicolaus' price target would indicate a potential upside of 21.68% from the stock's previous close.
Other equities research analysts also recently issued research reports about the stock. Canaccord Genuity Group started coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued a "buy" rating and a $52.00 price objective on the stock. Royal Bank Of Canada initiated coverage on shares of Hinge Health in a research note on Monday, June 16th. They set an "outperform" rating and a $45.00 price target on the stock. Needham & Company LLC initiated coverage on shares of Hinge Health in a research note on Monday, June 16th. They set a "buy" rating and a $47.00 price target on the stock. JMP Securities initiated coverage on shares of Hinge Health in a research note on Monday, July 14th. They set a "market outperform" rating and a $58.00 price target on the stock. Finally, KeyCorp lifted their price target on shares of Hinge Health from $45.00 to $60.00 and gave the stock an "overweight" rating in a research note on Monday, July 14th. One research analyst has rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $49.86.
Get Our Latest Research Report on HNGE
Hinge Health Trading Up 0.6%
Shares of Hinge Health stock traded up $0.25 during midday trading on Friday, hitting $45.20. The company had a trading volume of 231,500 shares, compared to its average volume of 868,966. The company's 50 day moving average price is $43.26. Hinge Health has a 1-year low of $33.42 and a 1-year high of $52.16.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. CHURCHILL MANAGEMENT Corp acquired a new stake in Hinge Health in the 2nd quarter valued at about $828,000. FNY Investment Advisers LLC bought a new stake in shares of Hinge Health in the 2nd quarter valued at about $310,000. Finally, Strategic Blueprint LLC bought a new stake in shares of Hinge Health in the 2nd quarter valued at about $346,000.
Hinge Health Company Profile
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.